Edgewise Therapeutics Inc
(EWTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,566 | 10,571 | 50,404 | 221,036 | 104,916 |
| Marketable Securities | 265,223 | 279,913 | 248,747 | 88,835 | 24,178 |
| TOTAL | $283,773 | $293,242 | $302,969 | $310,545 | $129,645 |
| Non-Current Assets | |||||
| PPE Net | 912 | 911 | 524 | 499 | 516 |
| Other Non-Current Assets | 548 | 295 | 0 | 201 | 975 |
| TOTAL | $1,460 | $1,206 | $524 | $700 | $1,491 |
| Total Assets | $285,233 | $294,448 | $303,493 | $311,245 | $131,136 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,843 | 2,292 | 2,816 | 1,621 | 1,580 |
| TOTAL | $10,521 | $8,754 | $6,739 | $4,851 | $4,342 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 329 | 295 | 0 | 0 | 0 |
| TOTAL | $329 | $295 | $N/A | $N/A | $N/A |
| Total Liabilities | $10,850 | $9,049 | $6,739 | $4,851 | $4,342 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,512 | 49,296 | 49,262 | 49,254 | N/A |
| Common Shares | 5 | 5 | 5 | 5 | N/A |
| Retained earnings | -76,960 | -64,264 | -51,315 | -40,962 | -34,147 |
| Other shareholders' equity | -514 | -24 | -33 | -54 | 160,214 |
| TOTAL | $274,383 | $285,399 | $296,754 | $306,394 | $126,794 |
| Total Liabilities And Equity | $285,233 | $294,448 | $303,493 | $311,245 | $131,136 |